Common Pitfalls in Multiple Sclerosis and CNS Demyelinating Diseases, Keegan
Автор: Cohen Название: Multiple Sclerosis Therapeutics ISBN: 0521766273 ISBN-13(EAN): 9780521766272 Издательство: Cambridge Academ Рейтинг: Цена: 22952.00 р. 32789.00-30% Наличие на складе: Есть (1 шт.) Описание: This book comprehensively reviews the current state of clinical trial methods in multiple sclerosis, providing investigators, sponsors and specialists with current knowledge of outcome measures and study designs for disease and symptom management of MS. The fourth edition has been extensively revised and features more than 50% new material.
Автор: Chabas Название: Demyelinating Disorders of the Central Nervous System in Childhood ISBN: 0521763495 ISBN-13(EAN): 9780521763493 Издательство: Cambridge Academ Рейтинг: Цена: 4958.00 р. Наличие на складе: Есть (2 шт.) Описание: Although up to 5 per cent of those with multiple sclerosis experience symptoms before the age of 18, there is a lack of awareness about these diseases in childhood. Providing comprehensive coverage of these diseases in children, this book is essential reading for pediatric and adult neurologists and MS specialists.
Автор: Douglas S. Goodin Название: Multiple Sclerosis and Related Disorders,122 ISBN: 0444520015 ISBN-13(EAN): 9780444520012 Издательство: Elsevier Science Рейтинг: Цена: 32002.00 р. Наличие на складе: Поставка под заказ.
Описание: Multiple Sclerosis (MS) is generally understood to be an inflammatory autoimmune disease of the central nervous system. This title includes chapters on key topics including the genetics of MS, MRI imaging and MS, and the treatment options.
Автор: Weiner Название: Multiple Sclerosis: Diagnosis and Therapy ISBN: 0470654635 ISBN-13(EAN): 9780470654637 Издательство: Wiley Рейтинг: Цена: 12506.00 р. Наличие на складе: Поставка под заказ.
Описание: * Provides a practical guide to diagnosis and therapy * Editor has been involved in clinical and research aspects of MS for 30 years * Contains up-to-date therapeutic information .
Описание: Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. With their novel, multifaceted approach to basic science, the authors of this book offer help to clinicians and hope to patients.
ООО "Логосфера " Тел:+7(495) 980-12-10 www.logobook.ru